Moderator: Michael P. Steinmetz, MD
128. Posterior lumbar fusions (PLFs) at physician owned hospitals – reconsidering the restrictions of the affordable care act (ACA)
Azeem T. Malik, MBBS1; Frank M. Phillips, MD2; Jeffery Kim, MD1; Elizabeth Yu, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Midwest Orthopaedics At Rush, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
129. Presence of a surgical trainee does not affect patient outcomes in lumbar fusion surgery
Srikanth Divi, MD; Matthew S. Galetta, BA1; Dhruv K. Goyal, BA1; Taolin Fang, MD, PhD2; Kristen Nicholson, PhD3; D. Greg Anderson, MD3; Mark F. Kurd, MD4; Jeffrey A. Rihn, MD5; Ian D. Kaye, MD3; Barrett Woods, MD6; Kris E. Radcliff, MD7; Alan S. Hilibrand, MD3; Alexander R. Vaccaro, MD, PhD3; Christopher K. Kepler, MD, MBA1; Gregory D. Schroeder, MD2
1Philadelphia, PA, US; 2Rothman Institute, Thomas Jefferson University, Philadelphia, PA, US; 3Rothman Institute, Philadelphia, PA, US; 4Rothman Institute, Bryn Mawr, PA, US; 5Thomas Jefferson University Hospital, The Rothman Institute, Philadelphia, PA, US; 6Egg Harbor Twp, NJ, US; 7Rothman Institute, Thomas Jefferson University, Egg Harbor Township, NJ, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
130. Cold facts of surgical Tarlov Cysts
Marcelo Galarza, MD, PhD, MSc
University Hospital of Murcia Spain, Murcia, Spain
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
131. Primary single-level lumbar discectomy/decompression at a free-standing ambulatory surgery center (ASC) versus. a hospital-owned outpatient facility (HOPD) - an analysis of 90-day outcomes and costs
Azeem T. Malik, MBBS1; Frank M. Phillips, MD2; Sheldon Retchin, MD3; Wendy Xu, PhD3; Elizabeth Yu, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Midwest Orthopaedics At Rush, Chicago, IL, US; 3Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
132. Risk factors for cage migration and cage retropulsion following transforaminal lumbar interbody fusion
Man Kyu Park, MD
Parkweonwook Hospital, Busan, Republic of Korea
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
133. Patient reported outcomes following surgery for lumbar disc herniation: Comparison of a universal and multitier health care system
Oliver G. Ayling, MD1; Tamir Ailon, MD, MPH2; Nicolas Dea, MD, MSc, FRCSC3; Charles G. Fisher, MD, FRCSC, MHS4
1University of British Columbia, Division of Neurosurgery, Vancouver, BC, Canada; 2Vancouver Spine Surgery Institute, Vancouver, BC, Canada; 3Blusson Spinal Cord Center, Vancouver, BC, Canada; 4Vancouver General Hospital, Vancouver, BC, Canada
>FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
134. Surgeon volume affects short-and long-term surgical outcomes in idiopathic scoliosis
Vishal Sarwahi, MD1; Jesse M. Galina, BS2; Sayyida S. Hasan, BS3; Aaron M. Atlas, BS3; Alexander M. Satin, MD4; Dean C. Perfetti, MD, MPH5; Terry D. Amaral, MD6
1North Shore LIJ Health System, New Hyde Park, NY, US; 2New Hyde Path, US; 3Cohen Children's Medical Center, New Hyde Park, NY, US; 4Long Island Jewish Medical Center, New Hyde Park, NY, US; 5Department of Orthopedic Surgery, Long Island Jewish Medical Center, New Hyde Park, NY, US; 6Northwell Health, Lake Success, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion